Perrigo Company plc (PRGO)

Market Cap	3.46B
Revenue (ttm)	4.39B
Net Income (ttm)	-159.60M
Shares Out	136.43M
EPS (ttm)	-1.17
PE Ratio	n/a
Forward PE	8.23
Dividend	$1.16 (4.58%)
Ex-Dividend Date	Mar 7, 2025

Volume	1,875,666
Open	25.24
Previous Close	25.24
Day's Range	25.11 - 25.57
52-Week Range	23.14 - 33.46
Beta	0.54
Analysts	Buy
Price Target	35.00 (+38.12%)
Earnings Date	Feb 27, 2025

About PRGO

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health pr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Dec 16, 1991
• Employees: 9,140
• Stock Exchange: NYSE
• Ticker Symbol: PRGO
• Website: https://www.perrigo.com

Financial Performance

In 2023, Perrigo Company's revenue was $4.66 billion, an increase of 4.58% compared to the previous year's $4.45 billion. Losses were -$12.70 million, -90.97% less than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for PRGO stock is "Buy." The 12-month stock price forecast is $35.0, which is an increase of 38.12% from the latest price.

Price Target

$35.0

(38.12% upside)

Analyst Consensus: Buy